Cargando…

The improved cure fraction for esophageal cancer in Linzhou city

BACKGROUND: Survival of esophageal cancer in Linzhou was seen to increase over the past few decades and is higher than the average level of China due to the implementation of comprehensive prevention and control measures. In population-based studies, relative survival is a common index to approximat...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Shuzheng, Guo, Lanwei, Chen, Qiong, Yu, Liang, Li, Bianyun, Cao, Xiaoqin, Sun, Xibin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171140/
https://www.ncbi.nlm.nih.gov/pubmed/30285671
http://dx.doi.org/10.1186/s12885-018-4867-7
_version_ 1783360734255644672
author Liu, Shuzheng
Guo, Lanwei
Chen, Qiong
Yu, Liang
Li, Bianyun
Cao, Xiaoqin
Sun, Xibin
author_facet Liu, Shuzheng
Guo, Lanwei
Chen, Qiong
Yu, Liang
Li, Bianyun
Cao, Xiaoqin
Sun, Xibin
author_sort Liu, Shuzheng
collection PubMed
description BACKGROUND: Survival of esophageal cancer in Linzhou was seen to increase over the past few decades and is higher than the average level of China due to the implementation of comprehensive prevention and control measures. In population-based studies, relative survival is a common index to approximate disease-specific survival. However, the cure fraction maybe great interest to patients and physicians. This study aimed to investigate the cure fraction of esophageal cancer in Linzou city during 2003–2012 with a cure model. METHODS: We carried out a population-based study of 8067 esophageal cancer patients in the Linzhou city during 2003–2012. Flexible parametric cure models were used to estimate cure proportions and median survival times of uncured by year of diagnosed and age. In each model, an interaction between calendar year and age were included. All variables in the model were included both as constant and time-varying effects. RESULTS: The 5-year relative survival rate was increased in every age group from 2003 to 2012. The huge increase in the cure proportion was observed in each age group. At the year of 2011–2012, 79.8%, 58.0%, 123.4% and 162.7% improvements of cure proportion were seen in age group 19–49, 50–59, 60–69 and 70–99 years compared with year of 2003–2004. Meanwhile, survival of ‘uncured’ patients changed little in all age group. CONCLUSIONS: The improvement of survival in Linzhou city during 2003–2012 was mainly due to an increasing cure proportion. Huge improvement of cure fraction within short period is likely due to the organized screening of esophageal cancer in Linzhou city.
format Online
Article
Text
id pubmed-6171140
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-61711402018-10-10 The improved cure fraction for esophageal cancer in Linzhou city Liu, Shuzheng Guo, Lanwei Chen, Qiong Yu, Liang Li, Bianyun Cao, Xiaoqin Sun, Xibin BMC Cancer Research Article BACKGROUND: Survival of esophageal cancer in Linzhou was seen to increase over the past few decades and is higher than the average level of China due to the implementation of comprehensive prevention and control measures. In population-based studies, relative survival is a common index to approximate disease-specific survival. However, the cure fraction maybe great interest to patients and physicians. This study aimed to investigate the cure fraction of esophageal cancer in Linzou city during 2003–2012 with a cure model. METHODS: We carried out a population-based study of 8067 esophageal cancer patients in the Linzhou city during 2003–2012. Flexible parametric cure models were used to estimate cure proportions and median survival times of uncured by year of diagnosed and age. In each model, an interaction between calendar year and age were included. All variables in the model were included both as constant and time-varying effects. RESULTS: The 5-year relative survival rate was increased in every age group from 2003 to 2012. The huge increase in the cure proportion was observed in each age group. At the year of 2011–2012, 79.8%, 58.0%, 123.4% and 162.7% improvements of cure proportion were seen in age group 19–49, 50–59, 60–69 and 70–99 years compared with year of 2003–2004. Meanwhile, survival of ‘uncured’ patients changed little in all age group. CONCLUSIONS: The improvement of survival in Linzhou city during 2003–2012 was mainly due to an increasing cure proportion. Huge improvement of cure fraction within short period is likely due to the organized screening of esophageal cancer in Linzhou city. BioMed Central 2018-10-03 /pmc/articles/PMC6171140/ /pubmed/30285671 http://dx.doi.org/10.1186/s12885-018-4867-7 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Liu, Shuzheng
Guo, Lanwei
Chen, Qiong
Yu, Liang
Li, Bianyun
Cao, Xiaoqin
Sun, Xibin
The improved cure fraction for esophageal cancer in Linzhou city
title The improved cure fraction for esophageal cancer in Linzhou city
title_full The improved cure fraction for esophageal cancer in Linzhou city
title_fullStr The improved cure fraction for esophageal cancer in Linzhou city
title_full_unstemmed The improved cure fraction for esophageal cancer in Linzhou city
title_short The improved cure fraction for esophageal cancer in Linzhou city
title_sort improved cure fraction for esophageal cancer in linzhou city
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171140/
https://www.ncbi.nlm.nih.gov/pubmed/30285671
http://dx.doi.org/10.1186/s12885-018-4867-7
work_keys_str_mv AT liushuzheng theimprovedcurefractionforesophagealcancerinlinzhoucity
AT guolanwei theimprovedcurefractionforesophagealcancerinlinzhoucity
AT chenqiong theimprovedcurefractionforesophagealcancerinlinzhoucity
AT yuliang theimprovedcurefractionforesophagealcancerinlinzhoucity
AT libianyun theimprovedcurefractionforesophagealcancerinlinzhoucity
AT caoxiaoqin theimprovedcurefractionforesophagealcancerinlinzhoucity
AT sunxibin theimprovedcurefractionforesophagealcancerinlinzhoucity
AT liushuzheng improvedcurefractionforesophagealcancerinlinzhoucity
AT guolanwei improvedcurefractionforesophagealcancerinlinzhoucity
AT chenqiong improvedcurefractionforesophagealcancerinlinzhoucity
AT yuliang improvedcurefractionforesophagealcancerinlinzhoucity
AT libianyun improvedcurefractionforesophagealcancerinlinzhoucity
AT caoxiaoqin improvedcurefractionforesophagealcancerinlinzhoucity
AT sunxibin improvedcurefractionforesophagealcancerinlinzhoucity